L’Oréal inks agreement with Abolis Biotechnologies and Evonik September 12, 2024 L’Oréal has entered into a tri-party agreement with French biotech company, Abolis Biotechnologies and global specialty manufacturer, Evonik. Read the full article now! Log in Subscribe